Andre G. Marquette
Profile
Andre G.
Marquette held the position of Senior Director-Marketing at LivaNova USA, Inc. and Vice President-Marketing & Business Development at Nanospectra Biosciences, Inc. He received a graduate degree and an MBA from Rice University and an undergraduate degree from The University of Texas at Austin.
Former positions of Andre G. Marquette
| Companies | Position | End |
|---|---|---|
| CYBERONICS, INC. | Sales & Marketing | - |
Nanospectra Biosciences, Inc.
 Nanospectra Biosciences, Inc. Pharmaceuticals: MajorHealth Technology Nanospectra Biosciences, Inc. provides commercializing particle-based therapies the selective and precise thermal destruction of solid tumors. It develops AuroLase Therapy utilizing AuroShell Particles (also referred to as nanoshells) for the precise, particle-based thermal ablation of solid tumors. The company was founded by Naomi J. Halas, Jennifer L. West, and Daniel M. Watkins in 2002 and is headquartered in Houston, TX. | Sales & Marketing | - |
Training of Andre G. Marquette
| The University of Texas at Austin | Undergraduate Degree |
| Rice University | Graduate Degree |
Experiences
Positions held
Linked companies
| Private companies | 2 |
|---|---|
Nanospectra Biosciences, Inc.
Nanospectra Biosciences, Inc. Pharmaceuticals: MajorHealth Technology Nanospectra Biosciences, Inc. provides commercializing particle-based therapies the selective and precise thermal destruction of solid tumors. It develops AuroLase Therapy utilizing AuroShell Particles (also referred to as nanoshells) for the precise, particle-based thermal ablation of solid tumors. The company was founded by Naomi J. Halas, Jennifer L. West, and Daniel M. Watkins in 2002 and is headquartered in Houston, TX. | Health Technology |
LivaNova USA, Inc.
 LivaNova USA, Inc. Medical SpecialtiesHealth Technology LivaNova USA, Inc. engages in the design, development, sales, and marketing of implantable medical devices. It operates through providing neuromodulation therapy, vagus nerve stimulation therapy (VNS Therapy) for the treatment of refractory epilepsy, and treatment-resistant depression (TRD). The company was founded in 1987 and is headquartered in Granbury, TX. | Health Technology |
- Stock Market
- Insiders
- Andre G. Marquette
